Clinical Trial Update: Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects [Phase 3]

View source ↗

Summary

A Phase III clinical trial compares GZR18 Injection to Semaglutide (Wegovy) for obesity in adults and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GZR18 Injection
• WEGOVY (Semaglutide)

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Obesity/Overweight in Adult | Phase 3 | Status: RECRUITING